385 top medical experts on Neurofibromatoses across 42 countries and 31 U.S. states, including 225 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Neurofibromatoses: A group of disorders characterized by an autosomal dominant pattern of inheritance with high rates of spontaneous mutation and multiple neurofibromas or neurilemmomas. neurofibromatosis 1 (generalized neurofibromatosis) accounts for approximately 95% of cases, although multiple additional subtypes (e.g., neurofibromatosis 2, neurofibromatosis 3, etc.) have been described. (From Neurochirurgie 1998 Nov;44(4):267-72)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Hereditary Neoplastic Syndromes (1,826), Nervous System Heredodegenerative Disorders (865), Neurocutaneous Syndromes (1,959), Neurofibroma (2,018) and Narrower Categories: Neurofibromatosis 1 (2,503), Neurofibromatosis 2 (1,949).
  4. Clinical Trials ClinicalTrials.gov : at least 206 including 24 Active, 87 Completed, 45 Recruiting
  5. Synonyms: Neurofibromatosis,  Neurofibromatosis Type 3


  

        

                    


    Computing Expert Listing ...

);